Fundraising Fox

Imagene

1 known investors

imagene-ai.com ↗

Imagene AI operates a SaaS platform built on a cross-modality intelligence engine that analyzes histopathology, gene expression, mutational profiles, and clinical records for biomarker discovery, patient identification and stratification, and trial design. It serves biopharma and clinical teams working in precision oncology.

AI & Machine LearningBiotechHealthtech

Founders & leadership

DBDean Bitan
Dean BitaninFounder

Investors · 1

Blumberg CapitalMiami · $500K – $5M

In the news

ImageneBio Reports Second Quarter 2026 Financial Results - BioSpacebiospace.com · Aug 2026Larry Ellison leads $23M Series B in Imagene AI to build ‘OpenAI for precision medici | Ctechcalcalistech.com · Jul 2025Imagene AI Hits $45M in Total Funding After Completing $23M Series B Led by Larry Ellisonfinance.yahoo.com · Jul 2025Imagene Raises $21.5M to Expand Image-Based Biomarker Detection for Precision Medicinehitconsultant.net · May 2022

Frequently asked questions

What does Imagene do?
Imagene AI operates a SaaS platform built on a cross-modality intelligence engine that analyzes histopathology, gene expression, mutational profiles, and clinical records for biomarker discovery, patient identification and stratification, and trial design. It serves biopharma and clinical teams working in precision oncology.
Who founded Imagene?
Imagene was founded by Dean Bitan.
Who are Imagene's investors?
Imagene's investors include Blumberg Capital.